Search research articles
Contact Us
Filters
Showing results (201-210 of 505) with videos related to
Page
of 51
Sort By:
Chest
|
July 11, 2024
Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial
Alexander G Mathioudakis, Sebastian Bate, Pradeesh Sivapalan, et al.
The European Respiratory Journal
|
October 28, 2017
RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation
Catherine E Charron, Paul Russell, Kazuhiro Ito, et al.
Clinical Science (London, England : 1979)
|
January 22, 2026
Dysregulated iron metabolism associates with neutrophilic airway inflammation in COPD
James Baker, Andrew Higham, Christopher McCrae, et al.
Respiratory Research
|
May 31, 2024
The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study
Ji Eun Park, Eunyoung Lee, Dave Singh, et al.
Thorax
|
July 14, 2011
Non-invasive phenotyping using exhaled volatile organic compounds in asthma
Baharudin Ibrahim, Maria Basanta, Paul Cadden, et al.
Advances in Therapy
|
November 1, 2016
Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials
M Reza Maleki-Yazdi, Dave Singh, Antonio Anzueto, et al.
Journal of Family Medicine and Primary Care
|
January 10, 2025
Results from a UK consensus about the optimal prescribing of medium strength triple therapy in uncontrolled adult asthma patients in the NHS
Richard E K Russell, Darush Attar-Zadeh, Natalie Harper, et al.
Respiratory Research
|
December 21, 2019
Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study
Brian R Leaker, Dave Singh, Sam Lindgren, et al.
Respiratory Research
|
June 19, 2016
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
Dave Singh, Mina Gaga, Olaf Schmidt, et al.
Scientific Reports
|
August 4, 2017
Characterisation of lung macrophage subpopulations in COPD patients and controls
Jennifer A Dewhurst, Simon Lea, Elizabeth Hardaker, et al.
Page
of 51
Search research articles
Search
Showing results (201-210 of 505) with videos related to
Sort By:
Page
of 51
Chest
|
July 11, 2024
Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial
Alexander G Mathioudakis, Sebastian Bate, Pradeesh Sivapalan, et al.
The European Respiratory Journal
|
October 28, 2017
RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation
Catherine E Charron, Paul Russell, Kazuhiro Ito, et al.
Clinical Science (London, England : 1979)
|
January 22, 2026
Dysregulated iron metabolism associates with neutrophilic airway inflammation in COPD
James Baker, Andrew Higham, Christopher McCrae, et al.
Respiratory Research
|
May 31, 2024
The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study
Ji Eun Park, Eunyoung Lee, Dave Singh, et al.
Thorax
|
July 14, 2011
Non-invasive phenotyping using exhaled volatile organic compounds in asthma
Baharudin Ibrahim, Maria Basanta, Paul Cadden, et al.
Advances in Therapy
|
November 1, 2016
Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials
M Reza Maleki-Yazdi, Dave Singh, Antonio Anzueto, et al.
Journal of Family Medicine and Primary Care
|
January 10, 2025
Results from a UK consensus about the optimal prescribing of medium strength triple therapy in uncontrolled adult asthma patients in the NHS
Richard E K Russell, Darush Attar-Zadeh, Natalie Harper, et al.
Respiratory Research
|
December 21, 2019
Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study
Brian R Leaker, Dave Singh, Sam Lindgren, et al.
Respiratory Research
|
June 19, 2016
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
Dave Singh, Mina Gaga, Olaf Schmidt, et al.
Scientific Reports
|
August 4, 2017
Characterisation of lung macrophage subpopulations in COPD patients and controls
Jennifer A Dewhurst, Simon Lea, Elizabeth Hardaker, et al.
Page
of 51